Results 1 to 10 of about 210,319 (212)

Incremental Net Benefit and Incremental Cost-Effectiveness Ratio of COVID-19 Vaccination Campaigns: Systematic Review of Cost-Effectiveness Evidence [PDF]

Vaccines, 2023
SARS-CoV-2 vaccination has been the most effective tool to prevent COVID-19, significantly reducing deaths and hospitalizations worldwide. Vaccination has played a huge role in bringing the COVID-19 pandemic under control, even as the inequitable ...
Giuseppe Santoli, Mario Cesare Nurchis, Giovanna Elisa Calabrò, Gianfranco Damiani   +3 more
doaj   +5 more sources

Median-Based Incremental Cost-Effectiveness Ratio (ICER). [PDF]

J Stat Theory Pract, 2012
Cost-effectiveness analysis (CEA) is a type of economic evaluation that examines the costs and health outcomes of alternative strategies and has been extensively applied in health sciences. The incremental cost-effectiveness ratio (ICER), which represents the additional cost of one unit of outcome gained by one strategy compared with another, has ...
Bang H, Zhao H.
europepmc   +4 more sources

Cost-Effectiveness of Cetuximab for Advanced Esophageal Squamous Cell Carcinoma. [PDF]

PLoS ONE, 2016
BACKGROUND:Costly biologicals in palliative oncology are emerging at a rapid pace. For example, in patients with advanced esophageal squamous cell carcinoma addition of cetuximab to a palliative chemotherapy regimen appears to improve survival.
Vincent T Janmaat, Marco J Bruno, Suzanne Polinder, Sylvie Lorenzen, Florian Lordick, Maikel P Peppelenbosch, Manon C W Spaander   +6 more
doaj   +4 more sources

Universal Dental Adhesives: Cost-Effectiveness and Duration of Use

Applied Sciences, 2022
The purpose of this study was to conduct a cost-effectiveness analysis (CEA) of different brands of universal dental adhesives used for composite restorations.
Ayman A. Banjar, Hani M. Nassar
doaj   +1 more source

How reliable are ICER’s results published in current pharmacoeconomic literature? The controversial issue of price confidentiality

Global & Regional Health Technology Assessment, 2022
Pharmacoeconomic data are widely used along drug life cycle for supporting decision-making processes on research and development, pricing and reimbursement, and market access.
Pierluigi Russo
doaj   +1 more source

Cost‐utility analysis of add‐on dapagliflozin in heart failure with reduced ejection fraction in the Philippines

ESC Heart Failure, 2021
Aim We aim to determine the cost‐effectiveness of dapagliflozin in addition to standard therapy versus standard therapy alone among patients with heart failure with reduced ejection fraction (HFrEF) using the public healthcare provider's perspective in ...
Victor L. Mendoza, Bernadette A. Tumanan‐Mendoza, Felix Eduardo R. Punzalan   +2 more
doaj   +1 more source

Optimal control and cost-effectiveness analysis for dengue fever model with asymptomatic and partial immune individuals

Results in Physics, 2021
Dengue is a vector-borne disease with an increasing incidence worldwide, and it is transmitted by the bites of mosquitoes infected with dengue viruses. This viral infection persistently affects economic sectors and public health.
Joshua Kiddy K. Asamoah, Ernest Yankson, Eric Okyere, Gui-Quan Sun, Zhen Jin, Rashid Jan, Fatmawati   +6 more
doaj   +1 more source

Cost-effectiveness of left ventricular assist devices (LVADs) for patients with advanced heart failure : analysis of the British NHS Bridge to Transplant (BTT) program [PDF]

, 2001
Background: A previous cost-effectiveness analysis showed that bridge to transplant (BTT) with early design left ventricular assist devices (LVADs) for advanced heart failure was more expensive than medical management while appearing less beneficial ...
Aileen Clarke, Ruth Pulikottil-Jacob, Martin Connock, Gaurav Suri, Ngianga-Bakwin Kandala, Hendramoorthy Maheswaran, Nicholas R. Banner, Paul Sutcliffe, Aaronson, Garber, Weinstein, Slaughter, Temple, MacGowan, Clegg, Clegg, Sharples, Sharples, Sharples, Slaughter, Sharples, National Institute for Health and Clinical Excellence, Gohler, Rogers, Personal social services research unit, Briggs, Levy, Schaffer, Strueber, Rose, Stevenson, National Institute for Health and Clinical Excellence, Moreno, Pagani   +33 more
core   +19 more sources

Cost-effectiveness analysis of patent foramen ovale closure versus medical therapy alone after cryptogenic stroke.

PLoS ONE, 2022
BackgroundClosure of a patent foramen ovale reduces the risk of recurrent stroke compared with medical therapy alone in young patients with cryptogenic strokes revealed by randomized control trials.
Yoko Shijoh, Shota Saito, Zhehao Dai, Sachiko Ohde   +3 more
doaj   +3 more sources

Cost-effectiveness and feasibility of conditional economic incentives and motivational interviewing to improve HIV health outcomes of adolescents living with HIV in Anambra State, Nigeria

BMC Health Services Research, 2021
Background In sub-Saharan Africa, there is increasing mortality and morbidity of adolescents due to poor linkage, retention in HIV care and adherence to antiretroviral therapy (ART).
Obinna Ikechukwu Ekwunife, Chinelo Janefrances Ofomata, Charles Ebuka Okafor, Maureen Ugonwa Anetoh, Stephen Okorafor Kalu, Prince Udegbunam Ele, George Uchenna Eleje   +6 more
doaj   +1 more source